These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11787342)

  • 21. [Symptomatic management in multiple sclerosis].
    Pappalardo A; Patti F; Restivo DA; Reggio A
    Clin Ter; 2004; 155(11-12):505-28. PubMed ID: 15861966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings.
    Mark VW; Taub E; Bashir K; Uswatte G; Delgado A; Bowman MH; Bryson CC; McKay S; Cutter GR
    Mult Scler; 2008 Aug; 14(7):992-4. PubMed ID: 18573826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved fatigue in individuals with multiple sclerosis after participating in a short-term self-care programme.
    Navipour H; Madani H; Mohebbi MR; Navipour R; Roozbayani P; Paydar A
    NeuroRehabilitation; 2006; 21(1):37-41. PubMed ID: 16720936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and occupational therapy in the treatment of patients with multiple sclerosis.
    LaBan MM; Martin T; Pechur J; Sarnacki S
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):603-14, vii. PubMed ID: 9894112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rehabilitation therapy in multiple sclerosis].
    Terré-Boliart R; Orient-López F
    Rev Neurol; 2007 Apr 1-15; 44(7):426-31. PubMed ID: 17420969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical agents used in the management of chronic pain by physical therapists.
    Allen RJ
    Phys Med Rehabil Clin N Am; 2006 May; 17(2):315-45. PubMed ID: 16616270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reliability and validity of pain interference measures in persons with multiple sclerosis.
    Osborne TL; Raichle KA; Jensen MP; Ehde DM; Kraft G
    J Pain Symptom Manage; 2006 Sep; 32(3):217-29. PubMed ID: 16939846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Conception and evaluation of a group therapy intervention for patients with chronic pain disorders and applications for early retirement pensions].
    Schultze H; Bischoff C; v Pein A; Limbacher K
    Rehabilitation (Stuttg); 2008 Aug; 47(4):211-8. PubMed ID: 18704870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine mechanisms in fibromyalgia-chronic fatigue.
    Buskila D; Press J
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):747-58. PubMed ID: 11812019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study of an energy conservation education program delivered by telephone conference call to people with multiple sclerosis.
    Finlayson M
    NeuroRehabilitation; 2005; 20(4):267-77. PubMed ID: 16403995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances.
    Smith PF
    Expert Rev Neurother; 2007 Sep; 7(9):1157-63. PubMed ID: 17868014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Symptomatic therapy of multiple sclerosis].
    Henze T
    Nervenarzt; 2004 Aug; 75 Suppl 1():2-39. PubMed ID: 15480526
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neuropsychologic examination and rehabilitation of multiple sclerosis patients].
    Saunamäki T; Hänninen R; Suhonen J
    Duodecim; 2005; 121(5):537-44. PubMed ID: 15839155
    [No Abstract]   [Full Text] [Related]  

  • 34. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing musculoskeletal complaints with rehabilitation therapy: summary of the Philadelphia Panel evidence-based clinical practice guidelines on musculoskeletal rehabilitation interventions.
    Harris GR; Susman JL
    J Fam Pract; 2002 Dec; 51(12):1042-6. PubMed ID: 12540330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B; Himmerich H; Wellek A; Oertel WH; Sommer N
    MMW Fortschr Med; 2007 May; 149 Suppl 2():51-5. PubMed ID: 17724968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of spasticity in hereditary spastic paraplegia.
    Richardson D; Thompson AJ
    Physiother Res Int; 1999; 4(1):68-76. PubMed ID: 10368840
    [No Abstract]   [Full Text] [Related]  

  • 38. A geriatrician's guide to the use of the physical modalities in the treatment of pain and dysfunction.
    Perret DM; Rim J; Cristian A
    Clin Geriatr Med; 2006 May; 22(2):331-54; ix. PubMed ID: 16627082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
    Kubsik A; Klimkiewicz P; Woldańska-Okońska M
    Wiad Lek; 2012; 65(1):55-61. PubMed ID: 22827117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and physical activity behavior in individuals with multiple sclerosis.
    Motl RW; Snook EM; Schapiro RT
    Res Nurs Health; 2008 Oct; 31(5):466-75. PubMed ID: 18286635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.